Arrowhead Research | ARWR - Interest Income


Arrowhead Research reported $9.05M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.05M 1.97M Sep/2025
Incyte USD 25.14M 2.21M Jun/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Ligand Pharmaceuticals USD 1.62M 150K Jun/2025
Merck USD 96M 27M Sep/2025
Moderna USD 81M 9M Jun/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025
Xencor USD 7.25M 290K Jun/2025